Join Us in Stopping the Deadliest Childhood Cancer
13. 100. 1.
On their own, these numbers may not mean a lot. However, within the pediatric brain tumor community, they’re everything.
- Each day, 13 children and adolescents are diagnosed with a primary brain tumor.
- More than 100 types of brain tumors make diagnosis and treatment difficult.
- Brain tumors are the number one cause of cancer-related deaths in children.
These numbers – and every child they represent - are why the PBTF has invested more than $29 million in pediatric brain tumor research over the past 30 years.
They’re also why we need to accelerate this investment as a community.
“The development of curative therapies for children with brain tumors is one of the most formidable challenges that pediatric oncologists face,” says Susan Blaney, MD, Deputy Director of the Texas Children’s Cancer and Hematology Centers, and Executive Vice Chair of the Department of Pediatrics at Baylor College of Medicine.
Susan Blaney, MD
Blaney has focused her career on the development of new treatments and treatment approaches for children with brain tumors.
“Almost 30 years ago, the parents of a dying boy with a brain tumor desperately asked me why there wasn’t more pediatric brain tumor research. From that day forward, I started to focus my clinical translational research efforts in this area. Although we have made some progress in positively impacting the outcome for children with brain tumors, this progress is limited when compared to other tumors. Nevertheless, we are in a very exciting era of discovery where new insights into the biology of pediatric brain tumors are being made on a daily basis.”
Success does not happen by accident, though. New treatments are not discovered by chance. Finding a cure requires our collective commitment.
In our new Strategic Plan, we’ve set objectives that look ahead to 2025, including growing our annual research investment to $12 million per year. And that growth starts now.
Donate directly to pediatric brain tumor research and help fund programs to ultimately eliminate the deadliest childhood cancer.
“With adequate resources to fund ongoing and future research efforts, I am confident that we will be able to improve the outcome for all children with pediatric brain tumors and that one day we will be able to cure all children with brain tumors using less toxic therapies,” says Blaney.
To ensure our research funding makes the greatest impact, we partner with top childhood brain tumor experts on our Research Advisory Network. These scientific advisors contribute insights that help shape funding priorities and evaluate the impact of our research investment on the lives of children diagnosed with a brain tumor.
Pave the way for better treatments, increased survivorship and a higher quality of life. Give now.